You are here
Competition Commission of Singapore halts Cordlife probe
THE Competition Commission of Singapore (CCS) has stopped its investigation into whether Cordlife Group's exclusive agreements with certain baby fair organisers and hospitals limit competition.
CCS's competition concerns were addressed by Cordlife's "voluntary commitments in good faith not to rely on the exclusive arrangements that were the subject of the investigation", said the group in a Singapore Exchange (SGX) announcement on Wednesday.
Cordlife added that the terms of its commitments to CCS will have no material impact on the finances, business and operations of the company, which will continue as usual.